Exelixis Inc at Piper Sandler Healthcare Conference Transcript
Good morning. Thank you all for joining us for the 34th Annual Piper Sandler Healthcare Conference. My name is Do Kim. I'm one of the Biotech Analysts here at Piper. For our next company presentation, we have Exelixis. And it's my pleasure to welcome Andrew Peters, Senior Vice President and Head of Strategy at Exelixis.
Questions & Answers
Andrew, maybe we could start in your area of expertise and talk about the number of collaborations, licensing deals that were done recently, primarily for assets in the early stages. Maybe you could expand on how you think about the strategic decision to go after early stage assets versus mid to late stage or a straight-out acquisition with your cash balance?
Yes. So happy to get into that, and thank you for having us and presenting at the conference.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
